BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31039244)

  • 1. Hospitalization Outcomes for Inflammatory Bowel Disease in Teaching vs Nonteaching Hospitals.
    Dalal RS; Vajravelu RK; Lewis JD; Lichtenstein GR
    Inflamm Bowel Dis; 2019 Nov; 25(12):1974-1982. PubMed ID: 31039244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile co-infection in inflammatory bowel disease is associated with significantly increased in-hospital mortality.
    Rezapour M; Galoosian A; Liu B; Bhuket T; Wong RJ
    Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1041-1046. PubMed ID: 29894325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory Bowel Disease Does Not Impact Mortality but Increases Length of Hospitalization in Patients with Acute Myocardial Infarction.
    Sinh P; Tabibian JH; Biyani PS; Mehta K; Mansoor E; Loftus EV; Dave M
    Dig Dis Sci; 2021 Dec; 66(12):4169-4177. PubMed ID: 33492533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nationwide patterns of hospitalizations to centers with high volume of admissions for inflammatory bowel disease and their impact on mortality.
    Nguyen GC; Steinhart AH
    Inflamm Bowel Dis; 2008 Dec; 14(12):1688-94. PubMed ID: 18623172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
    Park KT; Ehrlich OG; Allen JI; Meadows P; Szigethy EM; Henrichsen K; Kim SC; Lawton RC; Murphy SM; Regueiro M; Rubin DT; Engel-Nitz NM; Heller CA
    Inflamm Bowel Dis; 2020 Jan; 26(1):1-10. PubMed ID: 31112238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rising Incidence of Intestinal Infections in Inflammatory Bowel Disease: A Nationwide Analysis.
    Barber GE; Hendler S; Okafor P; Limsui D; Limketkai BN
    Inflamm Bowel Dis; 2018 Jul; 24(8):1849-1856. PubMed ID: 29722832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of Laboratory Testing in Teaching vs Nonteaching Hospitals for 2 Common Medical Conditions.
    Valencia V; Arora VM; Ranji SR; Meza C; Moriates C
    JAMA Intern Med; 2018 Jan; 178(1):39-47. PubMed ID: 29131899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct medical cost of managing IBD patients: a Canadian population-based study.
    Bernstein CN; Longobardi T; Finlayson G; Blanchard JF
    Inflamm Bowel Dis; 2012 Aug; 18(8):1498-508. PubMed ID: 22109958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National burden of pediatric hospitalizations for inflammatory bowel disease: results from the 2006 Kids' Inpatient Database.
    Heaton PC; Tundia NL; Schmidt N; Wigle PR; Kelton CM
    J Pediatr Gastroenterol Nutr; 2012 Apr; 54(4):477-85. PubMed ID: 22027564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
    Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
    Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.
    van der Valk ME; Mangen MJ; Leenders M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk CJ; Vermeijden JR; Siersema PD; van Oijen MG; Oldenburg B;
    Gut; 2014 Jan; 63(1):72-9. PubMed ID: 23135759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Trends and In-Hospital Outcomes of Adult Patients With Inflammatory Bowel Disease Receiving Parenteral Nutrition Support.
    Nguyen DL; Parekh N; Bechtold ML; Jamal MM
    JPEN J Parenter Enteral Nutr; 2016 Mar; 40(3):412-6. PubMed ID: 24687967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic analysis of annual health resource utilization and costs in hospitalized patients with inflammatory bowel disease in Switzerland.
    Schoepfer A; Vavricka SR; Brüngger B; Reich O; Blozik E; Bähler C
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):868-875. PubMed ID: 29757772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases.
    Ananthakrishnan AN; McGinley EL
    J Crohns Colitis; 2013 Mar; 7(2):107-12. PubMed ID: 22440891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Out-of-pocket Cost Burden in Pediatric Inflammatory Bowel Disease: A Cross-sectional Cohort Analysis.
    Sin AT; Damman JL; Ziring DA; Gleghorn EE; Garcia-Careaga MG; Gugig RR; Hunter AK; Burgis JC; Bass DM; Park KT
    Inflamm Bowel Dis; 2015 Jun; 21(6):1368-77. PubMed ID: 25839776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn's disease: a nationwide population-based cohort study.
    Ording AG; Horváth-Puhó E; Erichsen R; Long MD; Baron JA; Lash TL; Sørensen HT
    Inflamm Bowel Dis; 2013; 19(4):800-5. PubMed ID: 23435402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care costs associated with Australian tertiary inflammatory bowel disease care.
    Jackson B; Con D; Ma R; Gorelik A; Liew D; De Cruz P
    Scand J Gastroenterol; 2017 Aug; 52(8):851-856. PubMed ID: 28509590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital costs, length of stay and prevalence of hip and knee arthroplasty in patients with inflammatory bowel disease.
    Ehrenpreis ED; Zhou Y
    World J Gastroenterol; 2017 Jul; 23(26):4752-4758. PubMed ID: 28765696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005.
    Herrinton LJ; Liu L; Fireman B; Lewis JD; Allison JE; Flowers N; Hutfless S; Velayos FS; Abramson O; Altschuler A; Perry GS
    Gastroenterology; 2009 Aug; 137(2):502-11. PubMed ID: 19445944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.